We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cannabis Reduces Headache and Migraine Severity by Half

By HospiMedica International staff writers
Posted on 02 Dec 2019
Inhaled cannabis significantly reduces self-reported headache and migraine severity, according to a new study.

Researchers at Washington State University (WSU; Spokane, WA, USA) conducted a study that analyzed archival data from Strainprint, a smartphone app that allows patients to track their symptoms before and after consumption of medical cannabis purchased from Canadian producers and distributors. More...
The data analyzed was submitted by more than 1,300 patients, who used the app in 12,293 sessions to track changes in headache severity before and after cannabis use, and another 653 who used the app over 7,441 sessions to track changes in migraine severity.

The results showed a 47.3% reduction in headache severity and a 49.6% reduction in migraine ratings following cannabis use. Men reported larger headache reductions than women, and use of concentrates (such as cannabis oil), produced a larger reduction in headache severity ratings than cannabis flower. No significant difference in pain reduction was seen among strains that were higher or lower in levels of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), suggesting that other cannabinoids (or even terpenes), may promote headache and migraine relief. The study was published on November 9, 2019, in The Journal of Pain.

“I suspect there are some slight overestimates of effectiveness. My hope is that this research will motivate researchers to take on the difficult work of conducting placebo-controlled trials,” said lead author Carrie Cuttler, PhD, of the WSU Translational Addiction Research Center. “In the meantime, this at least gives medical cannabis patients and their doctors a little more information about what they might expect from using cannabis to manage these conditions.”

Cannabis, also known as Marijuana, is composed of dried buds and leaves of varieties of the Cannabis sativa plant. The two most active components in marijuana are THC and CBD, but there are over 100 cannabinoids in the plants themselves. THC seems to cause the euphoria reported by users, and helps relieve pain and nausea and reduce inflammation. CBD can help treat seizures, reduce anxiety and paranoia, and counteract the THC high.

Related Links:
Washington State University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.